ALPS Advisors’s Dyne Therapeutics DYN Stock Holding History

ALPS Advisors’s Portfolio DYN Stock Details DYN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3.71M	Buy	+167,082	New	+$3.11M	0.02%	356

Other funds holding DYN

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

YIH

Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return

AWM

Axxcess Wealth Management Carlsbad, California $6.28B AUM 24.26% 1-Year Est. Return

DWM

Darwin Wealth Management Tampa, Florida $365M AUM 22.69% 1-Year Est. Return

FISPB

Fideuram - Intesa Sanpaolo Private Banking Turin $3.33B AUM

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

PFSRSONJ

Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return

AssetMark Inc Concord, California $58.2B AUM 22.78% 1-Year Est. Return

CUAMC

China Universal Asset Management Company Shanghai, China $1.67B AUM 89% 1-Year Est. Return

ALPS Advisors's DYN Position: Q2 2026 in Review

ALPS Advisors opened a new position in Dyne Therapeutics (DYN) in Q2 2026: 167,082 shares worth $3.71M. The stake represents 0.02% of the portfolio and ranks #356 among its holdings.

36 funds tracked by Wall St. Rank hold DYN as of Q2 2026.

ALPS Advisors held 167,082 shares of Dyne Therapeutics worth $3.71M as of Q2 2026.
Dyne Therapeutics was a new ALPS Advisors position in Q2 2026.
Dyne Therapeutics made up 0.02% of ALPS Advisors's portfolio in Q2 2026, its #356 holding.
36 funds tracked by Wall St. Rank held Dyne Therapeutics as of Q2 2026.

Based on ALPS Advisors's 13F filing for Q2 2026, filed 29 Jul 2026.